Article in Molecules (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
12 authors.
Weslei Roberto Correia CabralLaboratório de Biologia Molecular de Microrganismos, Departamento de Microbiologia, Universidade Estadual de Londrina, Londrina 86055-900, Brazil.ORCID 0000-0002-7026-8593
Caio Ferreira de OliveiraDepartamento de Medicina, Faculdades de Dracena, Dracena 17910-106, Brazil.
Rogerio GiuffridaDepartamento de Medicina Veterinária, Universidade do Oeste Paulista, Presidente Prudente 19050-920, Brazil.ORCID 0000-0002-2380-4349
Lais Fernanda de Almeida SpoladoriLaboratório de Biologia Molecular de Microrganismos, Departamento de Microbiologia, Universidade Estadual de Londrina, Londrina 86055-900, Brazil.ORCID 0009-0005-8805-5747
Isabela Madeira de CastroLaboratório de Biologia Molecular de Microrganismos, Departamento de Microbiologia, Universidade Estadual de Londrina, Londrina 86055-900, Brazil.
Guilherme Bartolomeu-GonçalvesDepartamento de Patologia, Análises Clínicas e Toxicológicas, Universidade Estadual de Londrina, Londrina 86038-350, Brazil.ORCID 0000-0002-3497-5362
Helena Tiemi SuzukawaLaboratório de Biologia Molecular de Microrganismos, Departamento de Microbiologia, Universidade Estadual de Londrina, Londrina 86055-900, Brazil.ORCID 0000-0002-2694-6553
Gabriella Maria AndrianiLaboratório de Biologia Molecular de Microrganismos, Departamento de Microbiologia, Universidade Estadual de Londrina, Londrina 86055-900, Brazil.ORCID 0000-0002-8944-004X
Gerson NakazatoDepartamento de Microbiologia, Universidade Estadual de Londrina, Londrina 86055-900, Brazil.
Eliandro Reis TavaresLaboratório de Biologia Molecular de Microrganismos, Departamento de Microbiologia, Universidade Estadual de Londrina, Londrina 86055-900, Brazil.
Lucy Megumi YamauchiLaboratório de Biologia Molecular de Microrganismos, Departamento de Microbiologia, Universidade Estadual de Londrina, Londrina 86055-900, Brazil.ORCID 0000-0003-2241-8814
Sueli Fumie Yamada-OgattaLaboratório de Biologia Molecular de Microrganismos, Departamento de Microbiologia, Universidade Estadual de Londrina, Londrina 86055-900, Brazil.ORCID 0000-0003-1183-146X
Funding
Conselho Nacional de Desenvolvimento Científico e Tecnológico - CNPq Process 408547/2024-3Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) Financial Code 01Financiadora de Estudos e Projetos (FINEP)-MCTI 01.22.0200.00
6 · The paper itself
Abstract
Plants are a valuable source of bioactive compounds with therapeutic potential. Antibacterials of natural origin represent a promising and sustainable alternative in the fight against bacterial infections. In addition to being effective against bacterial growth, these natural agents may have lower toxicity and fewer side effects, which reinforces their value in the development of new therapeutic strategies. This study reports on the antibacterial effect of eugenol (EUG) and biogenic silver nanoparticles (bioAgNPs) synthesized using the aqueous extract of
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Synergistic Antibacterial Effect of Eugenol and Biogenic Silver Nanoparticles on · full record | OpenQuestion